Clinical Trial Update: Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and pharmacokinetics of ascending, multiple oral doses of SPD489 in adults with schizophrenia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SPD489

Snippet

Sponsor: Shire | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2013-01-21